TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Roche Diagnostics Norge AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 | 
| Turnover | 214,254 | 137,616 | 61,160 | 
| Financial expenses | 125 | 70 | 102 | 
| Earnings before taxes | 9,987 | 2,135 | 2,380 | 
| Total assets | 34,454 | 65,529 | 32,626 | 
| Current assets | 29,980 | 64,082 | 30,815 | 
| Current liabilities | 25,503 | 54,227 | 23,444 | 
| Equity capital | 8,952 | 11,302 | 9,183 | 
| - share capital | 555 | 586 | 555 | 
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 | 
| Solvency | 26.0% | 17.2% | 28.1% | 
| Turnover per employee | |||
| Profit as a percentage of turnover | 4.7% | 1.6% | 3.9% | 
| Return on assets (ROA) | 29.3% | 3.4% | 7.6% | 
| Current ratio | 117.6% | 118.2% | 131.4% | 
| Return on equity (ROE) | 111.6% | 18.9% | 25.9% | 
| Change turnover | 83,866 | 73,134 | 10,052 | 
| Change turnover % | 64% | 113% | 20% | 
| Chg. No. of employees | |||
| Chg. No. of employees % | 
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    